StoMakker: Improving the Quality of Life of Children Receiving an Ileostomy, Colostomy or Continent Urostomy by Offering Access to a Peer Support Platform, Age Dependent Information Provision and Games in a Smartphone Application
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Change from baseline in health-related quality of life of participants on the age specific 7 item PROMIS Pediatric Global Health scale (PGH-7) questionnaire at 6 months after surgery
Study Overview
Brief Summary
The goal of this clinical trial is to investigate if access to the StoMakker application will significantly improve health-related quality of life in children receiving surgery resulting in an ileostomy, colostomy or continent urostomy. The main question it aims to answer are:
- Does access to StoMakker improve health-related quality of life in children receiving surgery for an ostomy?
- Does access to StoMakker improve the anxiety and social functioning of children receiving surgery for an ostomy?
- Does access to StoMakker improve postoperative complications of children receiving surgery for an ostomy?
Participants will be asked to fill in several questionnaires around their surgery. The intervention group of the trial will be given access to the application "StoMakker". The control group of the trial will receive standard care.
Detailed Description
Peer support, patient education and -guidance are of crucial importance for children undergoing surgery for a stoma. Current supportive care is either lacking or via paper folders, which is not a suitable strategy for supporting this vulnerable group of children.
The main objective of this prospective trial is to investigate whether access to a peer support platform, age-dependent information provision and games using a smartphone application increases self-reported health related quality of life (HRQOL).
Study population: Children aged between 6 and 18 years old who will receive an ileostomy, colostomy or continent urostomy, are eligible for inclusion. Participants must have access to a smartphone or tablet. Children who are unable to use a smartphone due to mental or physical disabilities will be excluded from the study
Patients and their parents/caregivers are obliged to give written informed consent before they are allowed to be enrolled in the study.
The design of the study is an open-label multicenter randomized controlled trial with a follow-up of 6 months. The intervention group will get access to the app. The control group will receive standard care. Measurement is done via questionnaires, which are send at specificic intervals based on the surgery date. Parents or caregivers will also receive several questionnaires at specific intervals based on the surgery date.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 6 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Individuals scheduled for ileostomy, colostomy or continent urostomy surgery
- •Children aged between 6 and 18 years
- •Possession of, or continous access to a smartphone or tablet operated with iOS 9 and up or Android 8.0 and up
- •Access to email and internet
Exclusion Criteria
- •Incompetence of understanding the Dutch language
- •Visual impairment, unless well corrected with visual aids
- •Physical disabilities limiting the use of a mobile application
- •Mental disabilities limiting the use of a mobile application, learning and filling in questionnaires
- •Patients with pre-existing skin conditions such as pemphigus, para-pemphigus or psoriasis that may disturb or influence normal stoma care protocols
Arms & Interventions
Intervention
Access to the mobile application
Intervention: StoMakker (Device)
Control group
Standard care, without access to the application
Outcomes
Primary Outcomes
Change from baseline in health-related quality of life of participants on the age specific 7 item PROMIS Pediatric Global Health scale (PGH-7) questionnaire at 6 months after surgery
Time Frame: 6 months follow-up
The Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Global Health scale (PGH-7) is a validated self reported instrument for assessing general health. Scores range from 5 (low health-related quality of life) to 35 (high health-related quality of life). The questionnaire has been translated to dutch and validated in the Netherlands and dutch speaking Belgium Change = 6 month score - baseline
Secondary Outcomes
- Change from baseline in anxiety of participants on the age specific 8 item PROMIS pediatric v2.0 Anxiety and Depressive Symptoms, the short form 8a questionnaire at 6 months follow-up(6 months follow-up)
- Change from baseline in social functioning of participants on the age specific PROMIS pediatric item bank peer relationships short form 8a at 6 months after surgery(6 months follow-up)
- Occurrence of any surgery related complications as specified by the clavien-dindo classification within 6 months of follow-up.(6 months follow up)
Investigators
Marlies P. Schijven
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)